BNTX vs CGEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

BNTX

63.5
AI Score
VS
BNTX Wins

CGEN

63.3
AI Score

Investment Advisor Scores

BNTX

Oct 21, 2026
64score
Recommendation
STRONG BUY

CGEN

Oct 21, 2026
63score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric BNTX CGEN Winner
Forward P/E 7.0373 12.3609 BNTX
PEG Ratio 0.046 1.2874 BNTX
Revenue Growth -59.5% 107.0% CGEN
Earnings Growth -43.2% 0.0% CGEN
Tradestie Score 63.5/100 63.3/100 BNTX
Profit Margin -63.6% 47.6% CGEN
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation STRONG BUY STRONG BUY Tie

Relative Price Performance (Last 90 Days)

BNTX 1M: -8.9% · 3M: +0.4% CGEN 1M: -16.2% · 3M: -14.0%

Current Technical Phase

BNTX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.6 · Price: $89.67

CGEN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.1%), weak momentum, RSI 36

RSI (14): 35.9 · Price: $1.96

Fundamentals Snapshot

Metric BNTX CGEN
Market Cap — —
Forward P/E -18.6 -5.3
Trailing P/E — 5.6
Revenue (TTM) — —
Revenue Growth -0.6% 1.1%
Gross Margin 0.8% 0.9%
Operating Margin -8.1% -3.4%
EPS -7.83 0.38
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BNTX is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.